TGFBR1 haplotypes and risk of non-small-cell lung cancer

Cancer Research

Volumn 69, Issue 17, 2009, Pages 7046-7052

  Lei, Zhe ^a   Liu, Reng Yun ^a   Zhao, Jun ^a   Liu, Zeyi ^a   Jiang, Xiefang ^a   You, Weiming ^b   Chen, Xiao Feng ^a,c   Liu, Xia ^a   Zhang, Kui ^d   Pasche, Boris ^e   Zhang, Hong Tao ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b WUXI PEOPLE'S HOSPITAL   (China)

^c SHANGHAI PULMONARY HOSPITAL   (China)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM;

AGE FACTORS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SEX FACTORS;

EID: 70149099356     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4602     Document Type: Article

References (36)

1. Yang L, Parkin DM, Li LD, Chen YD, Bray F. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 2004;90:2157-2166
2. Shields PG. Molecular epidemiology of smoking and lung cancer. Oncogene 2002;21:6870-6876 (Pubitemid 35221933)
3. Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003;113:685-700. (Pubitemid 36724933)
4. Park C, Kim WS, Choi Y, Kim H, Park K. Effects of transforming growth factor β (TGF-β) receptor on lung carcinogenesis. Lung Cancer 2002;38:143-147
5. Zhao L, Sheldon K, Chen M, et al. The predictive role of plasma TGF-β1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer 2008;59:232-239 (Pubitemid 351173403)
6. Knaus PI, Lindemann D, DeCoteau JF, et al. A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 1996;16:3480-3489 (Pubitemid 26199867)
7. Kim IY, Ahn HJ, Lang S, et al. Loss of expression of transforming growth factor-β receptors is associated with poor prognosis in prostate cancer patients. Clin Cancer Res 1998;4:1625-1630 (Pubitemid 28304723)
8. Tokunaga H, Lee DH, Kim IY, Wheeler TM, Lerner SP. Decreased expression of transforming growth factor β receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients. Clin Cancer Res 1999;5:2520-2525 (Pubitemid 29437337)
9. Wagner M, Kleeff J, Friess H, Buchler MW, Korc M. Enhanced expression of the type II transforming growth factor-β receptor is associated with decreased survival in human pancreatic cancer. Pancreas 1999;19:370-376 (Pubitemid 29501433)
10. Colasante A, Aiello FB, Brunetti M, di Giovine FS. Gene expression of transforming growth factor β receptors I and II in non-small-cell lung tumors. Cytokine 2003;24:182-189 (Pubitemid 37330120)
11. Chen T, de Vries EG, Hollema H, et al. Structural alterations of transforming growth factor-β receptor genes in human cervical carcinoma. Int J Cancer 1999;82:43-51. (Pubitemid 29266105)
12. Pasche B, Kolachana P, Nafa K, et al. ThR-I(6A) is a candidate tumor susceptibility allele. Cancer Res 1999;59:5678-5682
13. Baxter SW, Choong DY, Eccles DM, Campbell IG. Transforming growth factor β receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2002;11:211-214
14. Song B, Margolin S, Skoglund J, et al. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-β receptor 1 in Swedish familial and sporadic breast cancer. Br J Cancer 2007;97:1175-1179 (Pubitemid 47586998)
15. Chen T, Jackson C, Costello B, et al. An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder. Int J Cancer 2004;112:420-425 (Pubitemid 39390606)
16. Chen T, Jackson CR, Link A, et al. Int7G24A variant of transforming growth factor-β receptor type I is associated with invasive breast cancer. Clin Cancer Res 2006;12:392-397 (Pubitemid 43166126)
17. You W, Liu Z, Zhao J, et al. No association between TGFBR1*6A and lung cancer. J Thorac Oncol 2007;2:657-659
18. Zhang HT, Fei QY, Chen F, et al. Mutational analysis of the transforming growth factor β receptor type I gene in primary non-small cell lung cancer. Lung Cancer 2003;40:281-287 (Pubitemid 36627707)
19. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265 (Pubitemid 40202029)
20. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-120 (Pubitemid 38085242)
21. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97-98 (Pubitemid 41653949)
22. Hung RJ, Christiani DC, Risch A, et al. International lung cancer consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev 2008;17:3081-3089
23. McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008;40:1404-1406
24. Akey J, Jin L, Xiong M. Haplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur J Hum Genet 2001;9:291-300.
25. Zeng Q, Phukan S, Xu Y, et al. Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development. Cancer Res 2009;69:678-686
26. Valle L, Serena-Acedo T, Liyanarachchi S, et al. Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer. Science 2008;321:1361-1365
27. Tang B, Bottinger EP, Jakowlew SB, et al. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency. Nat Med 1998;4:802-807 (Pubitemid 28331021)
28. Im YH, Kim HT, Kim IY, et al. Heterozygous mice for the transforming growth factor-β type II receptor gene have increased susceptibility to hepatocellular carcinogenesis. Cancer Res 2001;61:6665-6668
29. Chen T, Yan W, Wells RG, et al. Novel inactivating mutations of transforming growth factor-β type I receptor gene in head-and-neck cancer metastases. Int J Cancer 2001;93:653-661 (Pubitemid 32695112)
30. Chen T, Triplett J, Dehner B, et al. Transforming growth factor-β receptor type I gene is frequently mutated in ovarian carcinomas. Cancer Res 2001;61:4679-4682 (Pubitemid 32691875)
31. Wang D, Kanuma T, Mizunuma H, et al. Analysis of specific gene mutations in the transforming growth factor-β signal transduction pathway in human ovarian cancer. Cancer Res 2000;60:4507-4512 (Pubitemid 32103632)
32. Pasche B, Kaklamani V, Hou N, et al. TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. J Clin Oncol 2004;22:756-758
33. Zhang HT. Int7G24A variant of the TGFBR1 gene and cancer risk: a meta-analysis of three case-control studies. Lung Cancer 2005;49:419-420
34. Lucarini L, Sticchi E, Sofi F, et al. ACE and TGFBR1 genes interact in influencing the susceptibility to abdominal aortic aneurysm. Atherosclerosis 2009;202:205-210
35. Pasche B, Knobloch TJ, Bian Y, et al. Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA 2005;294:1634-1646 (Pubitemid 41407356)
36. Rosman DS, Phukan S, Huang CC, Pasche B. TGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation. Cancer Res 2008;68:1319-1328 (Pubitemid 351346838)